107
Participants
Start Date
February 28, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2011
Placebo
"* Placebo tablets, oral administration, twice daily for 10 weeks during randomized, double-blind treatment period. Duloxetine capsules, oral administration, 30 mg/day for 1 week after randomization to effect a duloxetine down-taper.~* Placebo tablets, twice daily for 1 week during double-blind down-taper treatment period."
Milnacipran
"* Milnacipran tablets, 100 to 200 mg/day, oral administration, twice daily in divided doses for 10 weeks during randomized, double-blind treatment period. Placebo capsules, 1 capsule/day administered for 1 week after randomization to maintain double-blind duloxetine down-taper.~* Milnacipran tablets, 100 to 0 mg/day, oral administration, twice daily in divided doses for 1 week during double-blind down-taper treatment period."
Forest Investigative Site 014, Syracuse
Forest Investigative Site 020, Mechanicsburg
Forest Investigative Site 023, Charlotte
Forest Investigative Site 011, Greer
Forest Investigative Site 006, Atlanta
Forest Investigative Site 024, Atlanta
Forest Investigative Site 009, Orlando
Forest Investigative Site 016, Orlando
Forest Investigative Site 007, Delray Beach
Forest Investigative Site 019, Tampa
Forest Investigative Site 012, St. Petersburg
Forest Investigative Site 008, Ocala
Forest Investigative Site 010, Jackson
Forest Investigative Site 003, Cleveland
Forest Investigative Site 002, Cincinnati
Forest Investigative Site 015, Evansville
Forest Investigative Site 026, Racine
Forest Investigative Site 025, St Louis
Forest Investigative Site 004, Salt Lake City
Forest Investigative Site 013, Sacramento
Forest Investigative Site 001, Medford
Forest Investigative Site 017, Bellevue
Forest Investigative Site 022, Cromwell
Forest Investigative Site 021, Danbury
Forest Investigative Site 005, Worchester
Forest Investigative Site 018, Willingboro
Lead Sponsor
Collaborators (1)
Cypress Bioscience, Inc.
INDUSTRY
Forest Laboratories
INDUSTRY